Michał Biśta

3.5k total citations · 1 hit paper
20 papers, 2.5k citations indexed

About

Michał Biśta is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Michał Biśta has authored 20 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Michał Biśta's work include Chemical Synthesis and Analysis (5 papers), Cancer-related Molecular Pathways (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Michał Biśta is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Cancer-related Molecular Pathways (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Michał Biśta collaborates with scholars based in United States, Germany and United Kingdom. Michał Biśta's co-authors include Tad A. Holak, Michael Sixt, Dieter E. Jenne, Dorothee Neukirchen, Zena Werb, Frank Bradke, Álvaro H. Crevenna, Roland Wedlich‐Söldner, Julia Riedl and Kai Kessenbrock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Michał Biśta

20 papers receiving 2.5k citations

Hit Papers

Lifeact: a versatile marker to visualize F-actin 2008 2026 2014 2020 2008 500 1000 1.5k

Peers

Michał Biśta
Emmanuel Derivery United Kingdom
Brad J. Nolen United States
Andrei V. Karginov United States
Félix Rivera-Molina United States
Roman Sakowicz United States
Michał Biśta
Citations per year, relative to Michał Biśta Michał Biśta (= 1×) peers Nils Johnsson

Countries citing papers authored by Michał Biśta

Since Specialization
Citations

This map shows the geographic impact of Michał Biśta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Biśta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Biśta more than expected).

Fields of papers citing papers by Michał Biśta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michał Biśta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Biśta. The network helps show where Michał Biśta may publish in the future.

Co-authorship network of co-authors of Michał Biśta

This figure shows the co-authorship network connecting the top 25 collaborators of Michał Biśta. A scholar is included among the top collaborators of Michał Biśta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michał Biśta. Michał Biśta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coelho, Matthew A., Étienne De Braekeleer, Mike Firth, et al.. (2020). CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs. Nature Communications. 11(1). 4132–4132. 58 indexed citations
2.
Lupták, Jakub, Michał Biśta, David I. Fisher, et al.. (2019). Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1. Acta Crystallographica Section D Structural Biology. 75(11). 1003–1014. 7 indexed citations
3.
Shaw, Joseph, Ian L. Dale, Paul Hemsley, et al.. (2018). Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1. SLAS DISCOVERY. 24(2). 121–132. 31 indexed citations
4.
Biśta, Michał, Matthew D. Newton, Anne U. Goeppert, et al.. (2017). Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease. Nature Communications. 8(1). 1610–1610. 54 indexed citations
5.
Biśta, Michał, Matthew Skinner, Christopher M. Hardy, et al.. (2017). Quantifying the relationship between inhibition of VEGF receptor 2, drug‐induced blood pressure elevation and hypertension. British Journal of Pharmacology. 175(4). 618–630. 16 indexed citations
6.
Nissink, J. Willem M., et al.. (2016). MTH1 Substrate Recognition—An Example of Specific Promiscuity. PLoS ONE. 11(3). e0151154–e0151154. 19 indexed citations
7.
Kettle, Jason G., Michał Biśta, J. Breed, et al.. (2016). Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival. Journal of Medicinal Chemistry. 59(6). 2346–2361. 100 indexed citations
8.
Biśta, Michał, Siglinde Wolf, Kareem Khoury, et al.. (2013). Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction. Structure. 21(12). 2143–2151. 47 indexed citations
9.
Biśta, Michał, Miriana Petrovich, & Alan R. Fersht. (2013). MDMX contains an autoinhibitory sequence element. Proceedings of the National Academy of Sciences. 110(44). 17814–17819. 45 indexed citations
10.
Biśta, Michał, Stefan M.V. Freund, & Alan R. Fersht. (2012). Domain–domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy. Proceedings of the National Academy of Sciences. 109(39). 15752–15756. 34 indexed citations
11.
Koes, David Ryan, Kareem Khoury, Yijun Huang, et al.. (2012). Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists. PLoS ONE. 7(3). e32839–e32839. 79 indexed citations
12.
Biśta, Michał, David C. Smithson, Katarzyna Pustelny, et al.. (2012). On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53. PLoS ONE. 7(6). e37518–e37518. 46 indexed citations
13.
Huang, Yijun, Siglinde Wolf, Michał Biśta, et al.. (2010). 1,4‐Thienodiazepine‐2,5‐diones via MCR (I): Synthesis, Virtual Space and p53‐Mdm2 Activity. Chemical Biology & Drug Design. 76(2). 116–129. 50 indexed citations
14.
Czarna, Anna, Barbara Beck, Stuti Srivastava, et al.. (2010). Robust Generation of Lead Compounds for Protein–Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists. Angewandte Chemie International Edition. 49(31). 5352–5356. 113 indexed citations
15.
Czarna, Anna, Barbara Beck, Stuti Srivastava, et al.. (2010). Robust Generation of Lead Compounds for Protein–Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists. Angewandte Chemie. 122(31). 5480–5484. 21 indexed citations
16.
Biśta, Michał, et al.. (2009). Robust NMR Screening for Lead Compounds Using Tryptophan-Containing Proteins. Journal of the American Chemical Society. 131(22). 7500–7501. 26 indexed citations
17.
Pustelny, Katarzyna, Michał Biśta, Kevin T. Boulware, et al.. (2009). Structural and functional characterization of SplA, an exclusively specific protease of Staphylococcus aureus. Biochemical Journal. 419(3). 555–564. 36 indexed citations
18.
Dubin, Grzegorz, Katarzyna Pustelny, Grzegorz M. Popowicz, et al.. (2008). Enzymatic Activity of the Staphylococcus aureus SplB Serine Protease is Induced by Substrates Containing the Sequence Trp-Glu-Leu-Gln. Journal of Molecular Biology. 379(2). 343–356. 39 indexed citations
19.
Riedl, Julia, Álvaro H. Crevenna, Kai Kessenbrock, et al.. (2008). Lifeact: a versatile marker to visualize F-actin. Nature Methods. 5(7). 605–607. 1702 indexed citations breakdown →
20.
Władyka, Benedykt, et al.. (2008). A novel member of the thermolysin family, cloning and biochemical characterization of metalloprotease from Staphylococcus pseudintermedius.. Acta Biochimica Polonica. 55(3). 525–536. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026